Drug Profile
Somatotropin biobetter - Ahn-Gook Pharma
Alternative Names: AG-B1512Latest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Biobetters; Growth hormones; Hormonal replacements
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Growth disorders
Most Recent Events
- 01 Nov 2021 Phase-I clinical trials in Growth disorders in South Korea (IV) (Ahn-Gook Pharmaceutical pipeline, November 2021)
- 01 Nov 2021 Phase-I clinical trials in Growth disorders in South Korea (SC) (Ahn-Gook Pharmaceutical pipeline, November 2021)
- 01 Oct 2021 Preclinical development for Growth-disorders is ongoing in South Korea (SC, IV) (Ahn-Gook Pharmaceutical pipeline, November 2021)